Stockreport

Sionna Therapeutics Prices Upsized Initial Public Offering

Sionna Therapeutics, Inc.  (SION) 
PDF BOSTON, Feb. 06, 2025 (GLOBE NEWSWIRE) -- Sionna Therapeutics Inc. (Nasdaq: SION), a clinical-stage biopharmaceutical company on a mission to revolutionize the current [Read more]